Evaluation of the bioequivalence of two formulations containing the combination of 400 mg of acetaminophen (paracetamol), 4 mg of phenylephrine and 4 mg of chlorpheniramine in capsules: open-label, three-way crossover study, partially replicated in health. Braz. J. Pharm. Sci. [Internet]. 2020 Dec. 9 [cited 2024 Apr. 30];56:e17836 . Available from: https://www.revistas.usp.br/bjps/article/view/181773